Aliceblue ANTInstall and trade smarter everywhere
Complete IPO details, including price band, financials, subscription status, and key insights.
Participate in the Aakaar Medical Technologies Ltd IPO with full transparency. Review issue details, company fundamentals, and financial performance, and apply securely through Alice Blue.
Key metrics and details at a glance.
Price Band
₹72
Per ShareLot Size
1600 Shares
Minimum Investment
₹1,15,200
Issue Size
₹27 Cr
Face Value
₹10
Per ShareIPO Type
Book Building - SME
Retail Quota
35%
QIB Quota
50%
NII Quota
15%
Important dates for your applying strategy.
Business model, operations, and market positioning.
Promoter Holding (Pre-Issue)
91.11%
Promoter Holding (Post-Issue)
67.01%
Issue Type
Book Building - SME
ISIN
INE1GYP01013
Incorporated in the year 2013, We are a medical aesthetic company dealing in a wide range of aesthetics & specialised cosmetic products & devices. Product range includes both Own brands (domestically manufactured products via loan licensing/ third party manufacturers) and distribution of products/devices of Imported Brands. We supply our products & devices primarily to aesthetic physicians such as dermatologists, plastic surgeons, aesthetic physicians who then sell these products to their end consumers as well as use certain device consumables as part of their treatments.
The global medical aesthetics and cosmetic dermatology market was valued at USD 35.9 Bn in CY2024 and is projected to reach USD 57.4 Bn by CY2030. The Indian medical aesthetics and cosmetic dermatology market generated a revenue of USD 283.9 Mn in CY2024 @ CAGR of 13.9% during the forecasted period to generate a revenue of USD 618.8 Mn in CY2030. Overall, the market is expected to expand globally, driven by technological innovation, growing consumer demand, and broader acceptance of aesthetic procedures.
Revenue, profit after tax and total assets across the last 3 reported financial years.
Amount in ₹ crore
How the company plans to utilize IPO proceeds.
The funds raised through this IPO will be used for:
Initial public offer of up to 37,50,400 equity shares of face value Rs. 10/- each (the "Equity Shares") of Aakaar Medical Technologies Limited' ("the Company" or the "issuer") for cash at a price of Rs. 72 per equity share (including securities premium of Rs. 62 per equity share) ("Issue Price"), aggregating up to Rs. 27 crores (the "Issue") of which 1,88,800 equity shares aggregating to Rs. 1.36 crores (Constituting up to 1.33 % of the post-issue paid-up equity share capital of the Company) will be reserved for subscription by market maker ("Market Maker Reservation Portion"). The issue less the market maker reservation portion is hereinafter referred to as the "Net Issue". The issue and the net issue will constitute 26.46% and 25.13 % respectively of the post-issue paid-up equity share capital of the company.
*Subject to approvals and market conditions.
Key competitive advantages and factors to consider before investing.
Live demand across investor categories.
Track real-time subscription levels:
*Real-time data subject to exchange updates
Aakaar Medical Technologies Limited was originally incorporated as `Aakaar Medical Technologies Private Limited', a private limited company under Companies Act, 1956, pursuant to a certificate of incorporation dated June 20, 2013 issued by the Registrar of Companies, Mumbai, Maharashtra. Subsequently, the Company was converted into a public limited company pursuant to a resolution passed by its shareholders at an Extra-ordinary General meeting held on July 19, 2024 and a fresh certificate of incorporation dated November 18, 2024 was issued by the RoC, Central Processing Centre consequent upon conversion, recording the change in name of the Company from `Aakaar Medical Technologies Private Limited' to 'Aakaar Medical Technologies Limited'.
wholesaler and Retailer
Amount in ₹ crore
Amount in ₹ crore
Figures in ₹ crore, on a standalone basis, as reported for FY24 to FY26.